Question · asked by 1 review
ZUCLOPENTHIXOL DECANOATE vs placebo: Quality of life/satisfaction with care for either recipients of care or carers: significant change in quality of life/satisfaction
- Population
- patients with schizophrenia
- Intervention
- ZUCLOPENTHIXOL DECANOATE
- Comparison
- placebo
- Outcome
- Quality of life/satisfaction with care for either recipients of care or carers: significant change in quality of life/satisfaction
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
ZUCLOPENTHIXOL DECANOATE vs PLACEBO Significant change in quality of life/satisfaction ‐ as defined by each of the studies · people with schizophrenia The review found no eligible studies for this question. Zuclopenthixol versus placebo for schizophrenia (2015) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Zuclopenthixol versus placebo for schizophrenia 2015 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.